BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 19331138)

  • 1. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
    Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
    Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.
    Buhmeida A; Algars A; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
    Oncology; 2006; 70(6):427-37. PubMed ID: 17220640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
    Bendardaf R; Buhmeida A; Hilska M; Laato M; Syrjänen S; Syrjänen K; Collan Y; Pyrhönen S
    Anticancer Res; 2008; 28(6B):3865-70. PubMed ID: 19192642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
    Gal R; Sadikov E; Sulkes J; Klein B; Koren R
    Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA quantitation by image analysis of paraffin-embedded colorectal adenocarcinomas and its prognostic value.
    Bosari S; Lee AK; Wiley BD; Heatley GJ; Hamilton WM; Silverman ML
    Mod Pathol; 1992 May; 5(3):324-8. PubMed ID: 1495937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
    Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.
    Buhmeida A; Algars A; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
    Anticancer Res; 2006; 26(1B):455-62. PubMed ID: 16739305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
    Lanza G; Maestri I; Dubini A; Gafà R
    Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
    Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
    Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-phase fraction can predict event free survival in patients with pT2-T3N0M0 colorectal carcinoma: implications for adjuvant chemotherapy.
    Cascinu S; Ligi M; Graziano F; Del Ferro E; Valentini M; Grianti C; Bartolucci M; Catalano G
    Cancer; 1998 Sep; 83(6):1081-5. PubMed ID: 9740071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of multiploidy as unfavorable prognostic variable in colorectal cancer.
    Cosimelli M; D'Agnano I; Tedesco M; D'Angelo C; Botti C; Giannarelli D; Vasselli S; Cavaliere F; Zupi G; Cavaliere R
    Anticancer Res; 1998; 18(3B):1957-65. PubMed ID: 9677450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.
    Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H
    Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.